Wangjun Yan
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Rheumatology top 10%
- Bone Tumor Diagnosis and Treatments
Papers in
- Rheumatology 20
- Bone Tumor Diagnosis and Treatments 15
-
- Sarcoma Diagnosis and Treatment 26
- Co-authors
- Xiangchun Zhang (2 shared papers)Chunmeng Wang (24 shared papers)Weiluo Cai (20 shared papers)Wending Huang (23 shared papers)Mo Cheng (16 shared papers)Yangbai Sun (15 shared papers)Zhengwang Sun (17 shared papers)Jinsong Zhang (1 shared paper)
- Journals
- European Spine Journal (4 papers)Cancer Medicine (4 papers)Annals of Oncology (3 papers)The Lancet Oncology (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Wangjun Yan
84 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 115
- Cancer Research 185
- Rheumatology 146
- Oncology 252
- Pulmonary and Respiratory Medicine 292
- Pathology and Forensic Medicine 154
Countries citing papers authored by Wangjun Yan
This map shows the geographic impact of Wangjun Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangjun Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangjun Yan more than expected).
Fields of papers citing papers by Wangjun Yan
This network shows the impact of papers produced by Wangjun Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangjun Yan. The network helps show where Wangjun Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Wangjun Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 205 | |
| 2 | 2021 | 137 | |
| 3 | 2011 | 113 | |
| 4 | 2022 | 53 | |
| 5 | 2013 | 50 | |
| 6 | 2020 | 46 | |
| 7 | 2019 | 46 | |
| 8 | 2024 | 44 | |
| 9 | 2011 | 37 | |
| 10 | 2014 | 35 | |
| 11 | 2019 | 34 | |
| 12 | 2021 | 30 | |
| 13 | 2015 | 29 | |
| 14 | 2022 | 29 | |
| 15 | 2014 | 27 | |
| 16 | 2009 | 25 | |
| 17 | 2019 | 24 | |
| 18 | 2022 | 22 | |
| 19 | 2018 | 21 | |
| 20 | 2018 | 20 |
About Wangjun Yan
Wangjun Yan is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 93 papers that have together received 1.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (26 papers), Bone Tumor Diagnosis and Treatments (15 papers), Vascular Tumors and Angiosarcomas (6 papers), Cutaneous Melanoma Detection and Management (5 papers), MicroRNA in disease regulation (5 papers), Nanoplatforms for cancer theranostics (5 papers), Cardiac tumors and thrombi (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Cancer Research (185 citations), Rheumatology (146 citations), Oncology (252 citations), Pulmonary and Respiratory Medicine (292 citations) and Pathology and Forensic Medicine (154 citations). Wangjun Yan has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xiangchun Zhang, Chunmeng Wang, Weiluo Cai, Wending Huang, Mo Cheng, Yangbai Sun, Zhengwang Sun, Jinsong Zhang, Zhichao Zhang and Chung Shu Yang. Their work appears in journals such as European Spine Journal, Cancer Medicine, Annals of Oncology, The Lancet Oncology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.